Pot stocks too expensive, says ‘dean of valuation’
Aswath Damodaran, NYU Stern Faculty of Industry, on the affect of the Canadian marijuana legalization match. With CNBC’s Aditi Roy and Melissa Lee, and the Immediate Cash traders, Tim Seymour,…
Senate hearing on cannabis trade and banking challenges – 07/23/2019
The Senate Banking, Housing and Urban Affairs Committee holds a hearing on cannabis trade and banking challenges. » Subscribe to CNBC TV: n» Subscribe to CNBC: C» Subscribe to CNBC…
Ohio votes to protect abortion rights as US states streak to the polls – BBC Recordsdata
The US affirm of Ohio has voted to enshrine abortion rights in its constitution, marking a well-known victory for official-preference campaigners in the affirm. Early returns confirmed nearly 56% of…
Tilray CEO Brendan Kennedy on hashish industry
CNBC’s “Energy Lunch” crew talks with Tilray CEO Brendan Kennedy about the expansion of the firm, the acquisition of Manitoba, and where the marketplace for hemp and CBD is headed….
There is a sizzling contemporary ETF that will perhaps enable you to play the cannabis dwelling
CNBC’s Bob Pisani breaks down YOLO, a 2nd marijuana-themed ETF that ultimate hit the market. Dave Nadig of ETF.com and Cantor Fitzgerald’s Reggie Brown weigh in.
Tilray CEO Irwin Simon: We’re correctly positioned no subject full U.S. legality of cannabis
Tilray CEO Irwin Simon joins ‘Dispute on the Avenue’ to discuss the firm’s quarterly earnings outcomes, whether or not investors perceive the firm’s growth yarn, and where the firm is…
Curaleaf Government Chairman: I feel we’re gonna accumulate a lag bipartisan vote from the Senate
Boris Jordan, Curaleaf govt chairman, joins ‘Immediate Money’ to discuss day after nowadays’s vote on the senate banking committee concerning cannabis companies banking privileges. For accumulate entry to to are…
Why is it so complex to salvage medicinal cannabis in the UK? – BBC News
Because it became once legalised 5 years in the past on occasion any sufferers in the UK had been prescribed clinical cannabis. Extinct to treat a series of clinical prerequisites,…
Cronos deal presents Altria a world cannabis platform, says analyst
CNBC’s “Vitality Lunch” workforce discusses Altria’s investment in cannabis firm Cronos with Christopher Growe, an analyst at Stifel.
Present stays severe factors for cannabis companies, says analyst
Vivien Azer, Cowen senior analyst and managing director, discusses her views on the cannabis sector sooner than Canada’s legalization.